| 000 | 01640 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250516025054.0 | ||
| 264 | 0 | _c20120117 | |
| 008 | 201201s 0 0 eng d | ||
| 022 | _a1108-7161 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFelsenberg, D | |
| 245 | 0 | 0 |
_aAdditive impact of alfacalcidol on bone mineral density and bone strength in alendronate treated postmenopausal women with reduced bone mass. _h[electronic resource] |
| 260 |
_bJournal of musculoskeletal & neuronal interactions _cMar 2011 |
||
| 300 |
_a34-45 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAlendronate _xadministration & dosage |
| 650 | 0 | 4 |
_aBone Density _xdrug effects |
| 650 | 0 | 4 |
_aBone Density Conservation Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aBone Resorption _xdrug therapy |
| 650 | 0 | 4 |
_aBone and Bones _xdrug effects |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydroxycholecalciferols _xadministration & dosage |
| 650 | 0 | 4 |
_aOsteoporosis, Postmenopausal _xdiagnostic imaging |
| 650 | 0 | 4 | _aRadiography |
| 700 | 1 | _aBock, O | |
| 700 | 1 | _aBörst, H | |
| 700 | 1 | _aArmbrecht, G | |
| 700 | 1 | _aBeller, G | |
| 700 | 1 | _aDegner, C | |
| 700 | 1 | _aStephan-Oelkers, M | |
| 700 | 1 | _aSchacht, E | |
| 700 | 1 | _aMazor, Z | |
| 700 | 1 | _aHashimoto, J | |
| 700 | 1 | _aRoth, H-J | |
| 700 | 1 | _aMartus, P | |
| 700 | 1 | _aRunge, M | |
| 773 | 0 |
_tJournal of musculoskeletal & neuronal interactions _gvol. 11 _gno. 1 _gp. 34-45 |
|
| 999 |
_c20637857 _d20637857 |
||